Tue, Aug 08, 2023
The company’s revenue increased 10 per cent YoY to Rs 2,591 crore in the June quarter as compared to Rs 2,347 crore in the same quarter last year. However, it was lower than the street estimates of Rs 2,639 crore.
More >
Wed, Aug 31, 2016
Following the FDC ban, this market fell by 3.9% to Rs 234 crore in the given quarter. Whereas drugs under NLEM grew by 1.6% to Rs 1061 crore, while non-NLEM drugs posted growth of 11.2% to Rs 7677 crore.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
